Allergan Buys Nash Therapy Maker Tobira at Huge Premium

Allergan plc announced a definitive deal to acquire Tobira Therapeutics, Inc. for a total potential consideration of around $1.7 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.